PubMed:33012858 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":53,"end":61},"obj":"Disease"},{"id":"T2","span":{"begin":180,"end":188},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.\nMelanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":51,"end":52},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":143,"end":148},"obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.\nMelanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1","span":{"begin":53,"end":63},"obj":"Species"},{"id":"3","span":{"begin":180,"end":190},"obj":"Species"}],"attributes":[{"id":"A1","pred":"tao:has_database_id","subj":"1","obj":"Tax:2697049"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.\nMelanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":72},"obj":"Sentence"},{"id":"T2","span":{"begin":73,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.\nMelanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims."}